vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $186.9M, roughly 1.5× Limbach Holdings, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 6.6%, a 89.7% gap on every dollar of revenue. On growth, Limbach Holdings, Inc. posted the faster year-over-year revenue change (30.1% vs 9.4%). Over the past eight quarters, Limbach Holdings, Inc.'s revenue compounded faster (25.3% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.
ACAD vs LMB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $186.9M |
| Net Profit | $273.6M | $12.3M |
| Gross Margin | 90.8% | 25.7% |
| Operating Margin | 6.1% | 9.4% |
| Net Margin | 96.3% | 6.6% |
| Revenue YoY | 9.4% | 30.1% |
| Net Profit YoY | 90.3% | 25.0% |
| EPS (diluted) | $1.61 | $1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $186.9M | ||
| Q3 25 | $278.6M | $184.6M | ||
| Q2 25 | $264.6M | $142.2M | ||
| Q1 25 | $244.3M | $133.1M | ||
| Q4 24 | $259.6M | $143.7M | ||
| Q3 24 | $250.4M | $133.9M | ||
| Q2 24 | $242.0M | $122.2M | ||
| Q1 24 | $205.8M | $119.0M |
| Q4 25 | $273.6M | $12.3M | ||
| Q3 25 | $71.8M | $8.8M | ||
| Q2 25 | $26.7M | $7.8M | ||
| Q1 25 | $19.0M | $10.2M | ||
| Q4 24 | $143.7M | $9.8M | ||
| Q3 24 | $32.8M | $7.5M | ||
| Q2 24 | $33.4M | $6.0M | ||
| Q1 24 | $16.6M | $7.6M |
| Q4 25 | 90.8% | 25.7% | ||
| Q3 25 | 92.2% | 24.2% | ||
| Q2 25 | 92.2% | 28.0% | ||
| Q1 25 | 91.7% | 27.6% | ||
| Q4 24 | 91.6% | 30.3% | ||
| Q3 24 | 92.5% | 27.0% | ||
| Q2 24 | 92.5% | 27.4% | ||
| Q1 24 | 88.8% | 26.1% |
| Q4 25 | 6.1% | 9.4% | ||
| Q3 25 | 12.8% | 7.2% | ||
| Q2 25 | 12.2% | 7.5% | ||
| Q1 25 | 7.9% | 5.9% | ||
| Q4 24 | 59.1% | 9.1% | ||
| Q3 24 | 12.6% | 8.1% | ||
| Q2 24 | 12.6% | 6.7% | ||
| Q1 24 | 7.4% | 5.5% |
| Q4 25 | 96.3% | 6.6% | ||
| Q3 25 | 25.8% | 4.8% | ||
| Q2 25 | 10.1% | 5.5% | ||
| Q1 25 | 7.8% | 7.7% | ||
| Q4 24 | 55.4% | 6.9% | ||
| Q3 24 | 13.1% | 5.6% | ||
| Q2 24 | 13.8% | 4.9% | ||
| Q1 24 | 8.0% | 6.4% |
| Q4 25 | $1.61 | $1.01 | ||
| Q3 25 | $0.42 | $0.73 | ||
| Q2 25 | $0.16 | $0.64 | ||
| Q1 25 | $0.11 | $0.85 | ||
| Q4 24 | $0.86 | $0.81 | ||
| Q3 24 | $0.20 | $0.62 | ||
| Q2 24 | $0.20 | $0.50 | ||
| Q1 24 | $0.10 | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $11.3M |
| Total DebtLower is stronger | — | $30.5M |
| Stockholders' EquityBook value | $1.2B | $195.7M |
| Total Assets | $1.6B | $381.1M |
| Debt / EquityLower = less leverage | — | 0.16× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $11.3M | ||
| Q3 25 | $258.0M | $9.8M | ||
| Q2 25 | $253.6M | $38.9M | ||
| Q1 25 | $217.7M | $38.1M | ||
| Q4 24 | $319.6M | $44.9M | ||
| Q3 24 | $155.1M | $51.2M | ||
| Q2 24 | $177.1M | $59.5M | ||
| Q1 24 | $204.7M | $48.2M |
| Q4 25 | — | $30.5M | ||
| Q3 25 | — | $56.3M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $23.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $19.7M | ||
| Q1 24 | — | $19.4M |
| Q4 25 | $1.2B | $195.7M | ||
| Q3 25 | $917.3M | $181.6M | ||
| Q2 25 | $822.4M | $170.5M | ||
| Q1 25 | $765.2M | $161.1M | ||
| Q4 24 | $732.8M | $153.5M | ||
| Q3 24 | $577.2M | $142.2M | ||
| Q2 24 | $516.7M | $133.0M | ||
| Q1 24 | $464.0M | $125.5M |
| Q4 25 | $1.6B | $381.1M | ||
| Q3 25 | $1.3B | $409.1M | ||
| Q2 25 | $1.2B | $343.0M | ||
| Q1 25 | $1.1B | $336.4M | ||
| Q4 24 | $1.2B | $352.1M | ||
| Q3 24 | $976.9M | $324.4M | ||
| Q2 24 | $914.1M | $303.9M | ||
| Q1 24 | $855.1M | $289.2M |
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $28.1M |
| Free Cash FlowOCF − Capex | — | $27.9M |
| FCF MarginFCF / Revenue | — | 14.9% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | -0.18× | 2.29× |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $28.1M | ||
| Q3 25 | $74.3M | $13.3M | ||
| Q2 25 | $64.0M | $2.0M | ||
| Q1 25 | $20.3M | $2.2M | ||
| Q4 24 | $40.4M | $19.3M | ||
| Q3 24 | $63.2M | $4.9M | ||
| Q2 24 | $25.0M | $16.5M | ||
| Q1 24 | $29.1M | $-3.9M |
| Q4 25 | — | $27.9M | ||
| Q3 25 | $73.9M | $12.8M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $11.0K | ||
| Q4 24 | — | $18.0M | ||
| Q3 24 | $63.2M | $4.6M | ||
| Q2 24 | — | $13.2M | ||
| Q1 24 | — | $-6.5M |
| Q4 25 | — | 14.9% | ||
| Q3 25 | 26.5% | 7.0% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | 25.2% | 3.4% | ||
| Q2 24 | — | 10.8% | ||
| Q1 24 | — | -5.5% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | -0.18× | 2.29× | ||
| Q3 25 | 1.03× | 1.52× | ||
| Q2 25 | 2.40× | 0.26× | ||
| Q1 25 | 1.07× | 0.22× | ||
| Q4 24 | 0.28× | 1.96× | ||
| Q3 24 | 1.93× | 0.66× | ||
| Q2 24 | 0.75× | 2.77× | ||
| Q1 24 | 1.76× | -0.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
LMB
| Owner Direct Relationships Segment | $145.0M | 78% |
| General Contractor Construction Manager Relationships Segment | $41.9M | 22% |
